A carregar...
Short-term efficacy and safety of lasmiditan, a novel 5-HT(1F) receptor agonist, for the acute treatment of migraine: a systematic review and meta-analysis
BACKGROUND: Migraine has been recognized as one of common diseases in the world whose current treatment options are not ideal. Lasmiditan, an oral 5-hydroxytryptamine (HT)(1F) receptor agonist, appears more promising for the acute treatment of migraine because of considerably better effect profiles...
Na minha lista:
| Publicado no: | J Headache Pain |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Milan
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7275414/ https://ncbi.nlm.nih.gov/pubmed/32503415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-020-01138-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|